Reduced FSH and LH action: implications for medically assisted reproduction.

Area of Science:

• Reproductive Endocrinology
• Molecular Biology
• Assisted Reproduction Technologies

Background:

• Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) are key regulators of reproductive function.
• Impaired production or action of LH and FSH leads to hypogonadism and reduced fertility.
• Reduced gonadotropin action is an under-recognized factor affecting fertility and treatment outcomes.

Purpose of the Study:

• To review the factors influencing reduced LH and FSH action.
• To explore the clinical implications of diminished gonadotropin action, particularly in assisted reproduction.
• To highlight the importance of gonadotropin action in ovarian stimulation response.

Main Methods:

• Literature review of studies on gonadotropin production and action.
• Analysis of molecular, signaling, aging, and genetic factors affecting gonadotropin action.
• Examination of clinical data related to ovarian stimulation and assisted reproduction outcomes.

Main Results:

• Reduced gonadotropin action can result from molecular characteristics, signaling pathway alterations, aging, and genetic polymorphisms.
• Diminished LH and FSH action, combined with reduced production in protocols like GnRH analogue use, can cause gonadotropin resistance.
• This resistance may lead to unexpected hypo-response during ovarian stimulation in fertility treatments.

Conclusions:

• Factors beyond gonadotropin production significantly impact reproductive success.
• Understanding the determinants of reduced LH and FSH action is critical for optimizing fertility treatments.
• Further research into gonadotropin action mechanisms can improve outcomes in assisted reproduction.